IFP Advisors, Inc - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 16.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,133
-76.2%
1,975
-50.0%
0.00%
Q2 2023$8,967
+37.1%
3,950
+96.3%
0.00%
Q1 2023$6,539
+81637.5%
2,012
-0.4%
0.00%
Q4 2022$8
-99.9%
2,020
-0.3%
0.00%
Q3 2022$8,0000.0%2,0270.0%0.00%
Q2 2022$8,000
-50.0%
2,027
-50.4%
0.00%
Q1 2022$16,000
+166.7%
4,083
+98.6%
0.00%
Q4 2021$6,000
-33.3%
2,056
-0.3%
0.00%
Q3 2021$9,000
+12.5%
2,062
-4.4%
0.00%
Q2 2021$8,000
+33.3%
2,157
+16.8%
0.00%
Q1 2021$6,000
+50.0%
1,846
+53.6%
0.00%
Q4 2020$4,000
+100.0%
1,202
+9.8%
0.00%
Q3 2020$2,0000.0%1,0950.0%0.00%
Q2 2020$2,0000.0%1,0950.0%0.00%
Q1 2020$2,0001,0950.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$1,0000.0%5000.0%0.00%
Q4 2018$1,0005000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders